Literature DB >> 32985204

MicroRNA-185 reduces the expression of hepatitis B virus surface antigen by targeting PRKCH in HepG2 2.2.15 cells.

Ronghua Zhang, Zhangxinyi Liu, Xiaoli Hou, Meimei Wang, Yanan Xiong, Hongjian Lu, Yitong Wang, Jinghui Su, Yutan Liu, Guangling Zhang, Yakun Liu.   

Abstract

MicroRNAs (miRNAs) are single-stranded noncoding RNAs with 18 to 25 nucleotides and play critical roles in a wide spectrum of biological processes. We repored that miR-185 inhibited hepatitis B surface antigen (HBsAg) expression and hepatitis B virus (HBV) replication without affecting the proliferation of HepG2 2.2.15 cells, compared with the controls. We identified that protein kinase C eta (PRKCH) is a direct target gene of miR-185 that affects HBV replication and protein expression and that the miR-185 may suppress HBV replication. Our results provide more information for gene therapy in HBV infection. Keywords: miR-185; HBV; HBV surface antigen; viral replication; PRKCH.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32985204     DOI: 10.4149/av_2020_304

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  1 in total

Review 1.  miRNAs as Potential Biomarkers for Viral Hepatitis B and C.

Authors:  Dimitri Loureiro; Issam Tout; Stéphanie Narguet; Sabrina Menasria Benazzouz; Abdellah Mansouri; Tarik Asselah
Journal:  Viruses       Date:  2020-12-14       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.